Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Wednesday, 31 January 2018

PCAS : NET SALES AS OF DECEMBER 31, 2017

PCAS    

Published: 17:45 CET 31-01-2018 /GlobeNewswire /Source: PCAS / : PCA /ISIN: FR0000053514


 

 

NET SALES AS OF DECEMBER 31, 2017

 

 

Longjumeau, January 31, 2018

PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales as of December 31, 2017.

 

The PCAS Group had generated consolidated net sales of €218.3 million as of December 31, 2017, representing growth of +13.7% compared to the same period of the previous financial year.

 

In millions of euros

 

2017

 

2016

 

% change

       

 Net sales as of 31 December

 

218.3 

 

192.0 

 

13.7%

  Pharmaceutical Synthesis

 

148.9 

 

130.0 

 

14.6%

  Fine Specialty Chemicals

 

69.3 

 

62.0 

 

11.8%

 

 

Pharmaceutical Synthesis

The Pharmaceutical Synthesis business generated €148.9 million, up 14.6% on 2016, which was especially driven by the Exclusive activity.

 

Fine Specialty Chemicals

Net sales of Fine Specialty Chemicals totaled €69.3 million, up 11.8% on 2016, with growth in both Performance Additives and Advanced Specialty Chemicals, more particularly for the micro-electronics part.

 

 

 

 

NEXT FINANCIAL DISCLOSURE:

2017 results, February 20, 2018

 

ABOUT PCAS 

PCAS specializes in the development and production of complex molecules for life sciences and innovative technologies. With 7% of its net sales earmarked for R&D and a large international footprint, PCAS is the preferred industrial partner for market-leading major global groups. Boasting especially high standards, the company offers a growing range of proprietary products and solutions in leading-edge segments. PCAS generated net sales of €218.3 million in 2017 and employs close to 1 100 people in six countries.

To find out more about PCAS, visit: www.pcas.com

    
   
  
 

 

 

 

 

 

 

 


PCAS

 

 

 

 

 

 


NewCap

Vincent Touraille / Eric Moissenot

PCAS

Emmanuel Huynh / Louis-Victor Delouvrier

NewCap

Financial communication and Investor Relations

Tel. : +33 1 69 79 61 32

www.pcas.com

 

Tel. : +33 1 44 71 98 53

pcas@newcap.eu

 

 



PCAS_2017 net sales



This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of Nasdaq Corporate Solutions clients. Source: PCAS, ZI de la Vigne aux Loups 23, rue Bossuet, LONGJUMEAU FR-91160, France
If you would like to unsubscribe and stop receiving these e-mails click here.